Free Trial

Avanos Medical (AVNS) Stock Price, News & Analysis

Avanos Medical logo
$12.35 -0.17 (-1.37%)
Closing price 03:59 PM Eastern
Extended Trading
$12.38 +0.04 (+0.28%)
As of 05:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Avanos Medical Stock (NYSE:AVNS)

Key Stats

Today's Range
$12.30
$12.49
50-Day Range
$12.05
$13.12
52-Week Range
$11.75
$25.36
Volume
281,315 shs
Average Volume
381,310 shs
Market Capitalization
$571.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Avanos Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
48th Percentile Overall Score

AVNS MarketRank™: 

Avanos Medical scored higher than 48% of companies evaluated by MarketBeat, and ranked 607th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Avanos Medical.

  • Earnings Growth

    Earnings for Avanos Medical are expected to grow by 31.06% in the coming year, from $1.32 to $1.73 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Avanos Medical is -1.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Avanos Medical is -1.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Avanos Medical has a P/B Ratio of 0.68. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Avanos Medical's valuation and earnings.
  • Percentage of Shares Shorted

    3.73% of the float of Avanos Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Avanos Medical has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Avanos Medical has recently increased by 7.05%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Avanos Medical does not currently pay a dividend.

  • Dividend Growth

    Avanos Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.73% of the float of Avanos Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Avanos Medical has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Avanos Medical has recently increased by 7.05%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Avanos Medical has a news sentiment score of 1.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.90 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Avanos Medical this week, compared to 3 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Avanos Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.64% of the stock of Avanos Medical is held by insiders.

  • Percentage Held by Institutions

    95.17% of the stock of Avanos Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Avanos Medical's insider trading history.
Receive AVNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter.

AVNS Stock News Headlines

The Pentagon just made a National Security move...
This "awesome resource" could power America for 30,000 years... We sent one of our smartest researchers.... a consultant who's worked for the likes of J.P. Morgan and Citicorp... into the middle of the Utah desert with a film crew.Why? So he could lead an investigation into a radical new kind of energy that's so abundant, the Dept. of Energy says it could meet America's power needs for the next 2 million years. It's got nothing to do with wind, solar, nuclear, oil or gas.
Q1 2025 Avanos Medical Inc Earnings Call
See More Headlines

AVNS Stock Analysis - Frequently Asked Questions

Avanos Medical's stock was trading at $15.92 at the beginning of 2025. Since then, AVNS stock has decreased by 22.4% and is now trading at $12.3490.
View the best growth stocks for 2025 here
.

Avanos Medical, Inc. (NYSE:AVNS) issued its quarterly earnings data on Tuesday, May, 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.07. Avanos Medical's quarterly revenue was up .8% compared to the same quarter last year.
Read the conference call transcript
.

Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Avanos Medical investors own include JPMorgan Chase & Co. (JPM), Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Home Depot (HD), Netflix (NFLX) and Tesla (TSLA).

Company Calendar

Last Earnings
5/06/2025
Today
7/02/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NYSE:AVNS
Fax
N/A
Employees
2,227
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
9.36
P/E Growth
N/A
Net Income
-$392.10 million
Pretax Margin
-57.33%

Debt

Sales & Book Value

Annual Sales
$687.80 million
Cash Flow
$11.99 per share
Price / Cash Flow
1.03
Book Value
$18.03 per share
Price / Book
0.68

Miscellaneous

Free Float
45,023,000
Market Cap
$571.02 million
Optionable
Optionable
Beta
1.12
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NYSE:AVNS) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners